Baseline and Early Post-Infusion Biomarkers Associated with Optimal Response to Idecabtagene Vicleucel (Ide-Cel) in the KarMMa-3 Study of Triple-Class–exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Tumor Regression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined